Ruipu got her Ph.D. degree from the South China University of Technology in Food Science under the supervision of Yonghua Wang. In Wang's group, Ruipu focused on the structural and catalytic mechanism of lipases/phospholipases and the application of functional lipids biosynthesis. Then, she moved to the National University of Singapore to be a research fellow in Zhi Li's group, where she first found a new enzyme that catalyzes the meinwald rearrangement to shift a methyl group in nature. During the Covid-19 pandemic, she moved to Shanghai to be a senior scientist in the protein design center of Wuxi Biologics to design therapeutic proteins and protein platforms to deliver drugs. To deeper her understanding of Disease biology, she began working at UCLA for Alzheimer's disease inhibitor design shortly. Currently, she works in the Chou Lab investigating the function of p97 and cofactors in diseases and is designing a protein platform to cross the Brain-Blood Barrier to deliver biomolecules. Outside the lab, she likes watching movies and documentaries to find the next place to travel.
Postdoc, National University of Singapore
Senior Scientist, Protein Design Center Wuxi Biologics, Shanghai
